As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...

Kiriayani Diaz remembers wanting to be a pediatrician when she was growing up. But as high school graduation approached in early 2021, she was undecided about which career path she wanted to take, and ...

The Pharmaceutical Sciences, Pharmaceutical Marketing and Management Option is perfect for students interested in careers that integrate science and business for a rewarding career in the ...

Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potential to Address a Significant Unmet Need in Lung Transplant Medicine and ...

In today’s Pharmaceutical Executive Daily, President Trump announces nine additional participants in the TrumpRx program, ...

VANCOUVER, British Columbia, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (XENE), a neurology-focused biopharmaceutical company, today announced it will provide updates on its ...

NEW YORK, December 08, 2025--(BUSINESS WIRE)--Hercules Pharmaceuticals (Hercules), a national leader in pharmaceutical distribution, today announced that it has been approved as an authorized ...

TORONTO, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") RVVTF RVV (FRANKFURT:31R), a specialty life sciences company focused on the research and development of ...

IRVING, Texas & DENVER--(BUSINESS WIRE)--Vizient Inc. and RISCS, Inc. today announced a joint pilot program aimed at enhancing assurance of pharmaceutical supply. Once implemented, the program would ...

TORONTO--(BUSINESS WIRE)--Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) released results from a neurotoxicity study of Ketamir-2, its novel oral NMDA receptor antagonist, on Tuesday. The U.S. Food and Drug Administration (FDA) ...